The Conversation Canada
📰 The Conversation (academic)
May 6, 2026
· 7 min read
Quick Score
○ Unverifiable
View full audit trail →
The peptide problem: Hype is outrunning the evidence
Original article ↗B.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.137
342 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Health Canada states that unauthorized injectable peptides are illegal in Canada, have not been assessed for safety, efficacy or quality, and may contain too much, too little or none of the claimed ingredient. (Unsplash+/Karolina Grabowska)
The peptide problem: Hype is outrunning the evidence
Published: May 6, 2026 11.53am EDT
Share article
Print article
Health Canada recently warned Canadians not to buy or inject unauthorized peptide drugs sold online, naming products that include BPC-157, CJC-1295, ipamorelin, TB-500 and retatrutide.
The advisory notes these products are being marketed o…
Read full article at The Conversation Canada ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.